Novo Nordisk Is Turning to New Factories to Boost Supply of Obesity Drug (NOVOB) - Bloomberg
Novo Nordisk CEO on EU pharma reform: "A lose, lose, lose" — MedWatch
Årets Leder 2020: »Jeg er aldrig blevet skuffet over, hvad folk kan« | Lederstof
Novo Nordisk on Twitter: "Vores CEO Lars Fruergaard Jørgensen er formand for regeringens klimapartnerskab for life science og biotek. Vi ser frem til samarbejdet om at bidrage til regeringens ambitiøse 2030-målsætning 🌎💪#dkgreen #
Lars Fruergaard Jørgensen – President & CEO at Novo Nordisk – Novo Nordisk | LinkedIn
Novo Nordisk CEO: Level of innovation determines our future
Novo Nordisk and Danish Government partner with UN-anchored initiative - Nordic Life Science – the leading Nordic life science news service
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/AI2IA4GTJNE5HDKXCJNBVSARXQ.jpg "Novo Nordisk, chastised for hiking insulin prices, makes a textbook response: More lobbying")
Novo Nordisk, chastised for hiking insulin prices, makes a textbook response: More lobbying
Novo Nordisk's new CEO leads it through its first tough period – European CEO
Novo Nordisk Forecasts Record Profit Fueled by Obesity Drug - Bloomberg
Novo Nordisk's new weight-loss drug getting a boost from pandemic -CEO | Reuters.com
Lars Jørgensen email address & phone number | Novo Nordisk President and CEO, Executive Vice President, Corporate Development contact information - RocketReach
Novo Nordisk CEO: "We are very encouraged by growth momentum" — MedWatch
A massive market beckons, but Novo CEO sees shared purpose in obesity
Pharma CEO: Gap between EU vision and national competencies affects health agenda – EURACTIV.com
Novo Nordisk boss Lars Fruergaard Jorgensen: We bring hope in the war on obesity
Lars Fruergaard (@LarsFruergaard) / Twitter
Novo Nordisk and the University of Toronto announce joint investment - Nordic Life Science – the leading Nordic life science news service
